Cholesterol news | Breaking cholesterol news | Cholesterol

Germany next on AstraZeneca's hit list

... A source at AstraZeneca also speculated that the company's US operations could be in for some trimming down in the near futureAs well as the jobs in production, over 500 jobs are also to be lost in AstraZeneca's German sales and marketing force following the failure of some of the company's development projects to reach market, and the impact of "growing pressure on physicians to prescribe patients older generic substances instead of innovative treatments."AstraZeneca are by no means the only big pharma scrambling to protect themselves in the face of generic competition and imminent patent expiries.

'Restructuring' seems to be the buzzword of choice in the pharma industry at the moment, with consolidation, plant closures and job cuts an unnervingly regular occurrence.As well as AstraZeneca's latest job cuts, Sanofi last month announced plans to shut its Irish over-the-counter (OTC) product manufacturing facility by the end of the year, and Bayer Healthcare confirmed the loss of almost 2,000 jobs in the fallout following Bayer's acquisition of Schering last year.Although a sizeable chunk of the planned 3,000 job loss...

Read more...

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | All news